Genpharmasec share news, announcements and annual reports
BSE: 531592Commercial Services & SuppliesSmall Cap
GENPHARMASEC LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1996
Last close ₹1.02up ₹0.03 (3.03%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.99.
2 Nov: open ₹1.00, high ₹1.03, low ₹0.98
52-week range of traded prices to 2 Nov 2026
₹0.75Low, 30 Mar 2026₹1.79High, 3 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹56 Cr3,222nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,52,702
Genpharmasec results
91 filed, newest first. Page 2 of 2.
Oct 2018
1 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2018
Jun 2018
May 2018
Dec 2017
Sep 2017
29 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Feb 2017
Dec 2016
15 Dec · Results
Nov 2016
Oct 2016
Aug 2016
May 2016
Mar 2016
Feb 2016
Nov 2015
Sep 2015
Aug 2015
14 Aug · Results
May 2015
Feb 2015
Nov 2014
Sep 2014
Aug 2014
Jul 2014
May 2014
Feb 2014
Nov 2013
Sep 2013
Aug 2013
May 2013
29 May · Results
Feb 2013
Nov 2012
16 Nov · Results
Aug 2012
24 Aug · Results
7 Aug · Results
Apr 2012
18 Apr · Results
Company has opted for submitting audited financial results for the year ended March 31, 2012 within 60 days from the end of financial year. ....
Jan 2012
25 Jan · Results
6 Jan · Results
Oct 2011
12 Oct · Results
May 2011
24 May · Results
Feb 2011
21 Feb · Results
21 Feb · Results